Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients

British Journal of Haematology

Volumn 102, Issue 4, 1998, Pages 1101-1106

  Kroger N ^a   Zeller, W ^a   Fehse, N ^a   Hassan, H T ^a   Kruger W ^a   Gutensohn, K ^a   Lolliger C ^a   Zander, A R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

CD34+ cells; G CSF; Malignant lymphoma; Mobilization; Peripheral stem cell support

Indexed keywords

BUSULFAN; CARMUSTINE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ADULT; ARTICLE; BONE PAIN; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFECT; DRUG TOLERANCE; FEMALE; HUMAN; LYMPHOMA; MALE; MYALGIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; COLONY-FORMING UNITS ASSAY; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FEMALE; FILGRASTIM; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; LYMPHOMA; MALE; MELPHALAN; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0031657989     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00865.x     Document Type: Article

References (33)

1. Bensinger, W.I., Appelbaum, F.R., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffmann, K., Weaver, C., Clift, R., Chauncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R. & Buckner, C.D. (1995) Factors that influence collection and engraftment of autologous peripheral stem cells. Journal of Clinical Oncology 13, 2547-2555.
2. Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., Higano, T., Klarnet, J., Chauncey, T., Storb, R. & Buckner, C.D. (1994) Peripheral blood stem cells collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematology, 87, 825-831.
3. Chao, N.J., Schriber, J.R., Griomes, K., Long, G.D., Negrin, R.S., Raimondi, C.M., Horning, S.J., Brown, S.L., Miller, L. & Blume, K.G. (1993) Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood, 81, 2031-2035.
4. Craig, W., Kay, R., Cutler, R.L. & Lansdorp, P.M. (1993) Expression of Thy-1 on human hematopoietic progenitor cells. Journal of Experimental Medicine, 177, 1331-1342.
5. Demirer, T., Buckner, C.D., Gooley, T., Appelbaum, F.R., Rowley, S., Chauncey, T., Lilleby, K., Storb, R. & Bensinger, W.I. (1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplantation, 17, 937-941.
6. Dreger, P., Klöss, M., Petersen, B., Haferlach, T., Löffler, H. & Schmitz, N. (1995) Autologous progenitor cell transplantation: prior exposure to stem cell toxic drugs determines yield and engraftment of peripheral blood progenitor cells but not of bone marrow cells. Blood, 86, 3970-3978.
7. Dreger, P., Marquardt, P., Haferlach, T., Jabobs, S., Mulverstedt, T., Eckstein, V., Suttorp, M., Löffler, H., Müller-Ruchholtz, W. & Schmitz, N. (1993) Effective mobilization of peripheral blood progenitor cells with Dexa-BEAM and G-CSF: timing of harvesting and composition of the leukapheresis product. British Journal of Cancer, 68, 950-957.
8. Gianni, A.M., Siena, S., Bregni, S., Stern, C., Tarella, C., Pileri, A. & Bonnadonna, G. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet, ii, 540-544.
9. 2) and granulocyte stimulating factor in patients with multiple myeloma. Bone Marrow Transplantation, 17, 691-697.
10. Haas, R., Moos, M., Karcher, R., Möhle, R., Witt, B., Goldschmidt, H., Frühauf, S., Flentiji, M., Wannenmacher, M. & Hunstein, W. (1994) Sequential high-dose therapy with peripheral blood progenitor cell support in low grade non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 1685-1692.
11. Haioun, C., Lepage, E., Gisselbrecht, C., Basson, Y., Coiffier, B., Brice, P., Bosly, A., Duprice, B., Nouvel, C., Tilly, H., Lederlin, P., Biron, P., Briere, J., Goulard, P. & Reyes, F. (1997) Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor risk aggressive non Hodgkin's lymphoma: update results of the prospective study LNH87-2. Journal of Clinical Oncology, 15, 1131-1131.
12. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K.C. & Cleary, M.L. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
13. Hassan, H.T., Krog, C., Stockschläder, M., Zeller, W., Krüger, W., Erttmann, R. & Zander, A.R. (1997) Factors influencing the haematological recovery after allogenic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GvHD prophylaxis: a single centre experience. Supportive Care Cancer, 57, 299-306.
14. Hassan, H.T., Zeller, W., Schleimer, B., Stockschläder, M., Krüger, W., Hoffknecht, M.M. & Zander, A.R. (1996a) CD34 positive cell selection using CellPro Ceprate in 55G-CSF mobilised peripheral blood grafts collected for transplantation. Bone Marrow Transplantation. 17, (Suppl. 1), 245.
15. Hassan, H.T., Zeller, W., Stockschläder, M., Krüger, W. Hoffknecht, M.M. & Zander, A.R. (1996) Comparison between bone marrow and G-CSF mobilized blood allograft undergoing clinical scale CD34 positive cell selection. Stem Cells, 14, 419-429.
16. Horning, S.J., Negrin, R.S., Chao, N.J., Long, G.D., Hoppe, R.T. & Blume, K.G. (1994) Fractionated total body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 2552-2558.
17. Jones, H.M., Jones, S.A., Watts, M.J., Khwaja, H., Mills, W., Fielding, J., Goldstone, A.H. & Linch, D.C. (1994) Development of a simplified single apheresis approach for peripheral-blood progenitor cell transplantation in previously treated patients with lymphoma. Journal of Clinical Oncology, 12, 1693-1702.
18. Kessinger, M., Bierman, P.J., Vose, J.M. & Armitage, J.O. (1991) High dose cyclophosphamide, carmustine and etoloside followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease. Blood, 77, 2322-2325.
19. Lennert, K. & Feller, A.C. (1990) Histopathalogie der Non-Hodgkin Lymphome. Springer, Berlin.
20. + cells for positive selection in newly diagnosed patients with myeloma and lymphoma. British Journal of Haematology, 92, 263-268.
21. McQuaker, I.G., Haynes, A.P., Stainer, C., Anderson, S. & Russell, N.H. (1997) Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, eoposide and epirubicin compared to intermediate-dose cyclophosphamide. British Journal of Heamatology. 98, 228-233.
22. + cells with a different antigenic profile compared with the use during steady-state hematopoiesis. Bone Marrow Transplantation, 14, 827-832.
23. Nademanee, A., Sniecinski, I., Schmidt, G.M., Dagis, A.C., O'Donnell, M.R., Snyder, D.S., Parker, P.M., Stein, A.S., Smith, E.P. Molina, R., Stepan, D.E., Somlo, G., Margolin, K.A., Wood, D., Niland, J.C. & Forman, S.J. (1994) High-dose therapy followed by autologous peripheral blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin' lymphoma using unprimed and granulocyte colony stimulating factor mobilized peripheral stem cells. Journal of Clinical Oncology, 12, 2176-2186.
24. Pettengell, R., Testa, N.G., Schwindell, R., Crowther, D. & Dexter, T.M. (1993) Transplantation potential of hematopoietic cells released into circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood, 82, 2239-2248.
25. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses in chemosensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
26. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Booggerts, M.A., Ferrant, A., Demuynck, H.M.S., Zander, A.R. & Borkett, K. (1996) A randomized trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet, 347, 3565-3567.
27. Schwartzberg, L.S., Birch, R. & Hazelton, B. (1992) Peripheral blood stem cell mobilization by chemotherapy with or without recombinant human granulocyte colony stimulating factor. Journal of Hematotherapy. 1, 317-327.
28. Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., To, L.B., Maher, D., McGrath, K.M., Morstyn, G. & Fox, R.M. (1992) Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640-644.
29. Siena, S., Bregni, M., Brando, B., Ravagnani, F., Bonnadonna, G. & Ganni, A.M. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400-409.
30. + CD38 progenitor cells. Blood, 77, 1218-1227.
31. To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Banford, A.L., Thorp, D., Ho, J.Q.K., Dart, G.W., Horvarth, N., Davy, M.L.J., Olweny, C.L.M., Abdi, E. & Juttner, C.A. (1992) Comparison of hematological recovery times and supportive care requirements for autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogenic bone marrow transplants. Bone Marrow Transplantation, 9, 277-284.
32. Weaver, C.H., Hazelton, B., Birsh, R., Palmer, P., Allen, C., Schwartzberg, L. & West, W. (1995) An analysis of engraftement kinetics as a function of the CD34 content of peripheral blood progenitor cell collection in 692 patients after administration of myeloablative chemotherapy. Blood, 86, 3961-3969.
33. Zeller, W., Gutensohn, K., Stockschläder, M., Dierlamm, J., Kröger, N., Könne, G., Hummel, K., Kabisch, H., Weh, H.J., Kühnl, P., Hossfled, D.K. & Zander, A.R. (1996) Increase of mobilized CD34 positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. Bone Marrow Transplantation, 17, 709-713.